Press release from Companies
Publicerat: 2026-03-26 10:00:00
The med-tech company PolarCool AB (publ.) announces that Achilles Capital AB has purchased an additional 100,000 shares, corresponding to approximately 1% of the company. Following the transaction, Achilles Capital will own approximately 26.5% of the shares in PolarCool.
PolarCool’s CEO Erik Andersson comments:
-We are glad that our major shareholder Achilles Capital has chosen to acquire an additional 100,000 shares, thereby increasing its ownership in the company. This is a clear vote of confidence in what we are doing and shows that they recognize the company’s significant potential, particularly in North America.
For more information
Erik Andersson – CEO PolarCool AB (publ.)
+46 – 73 860 57 00
E-mail: erik.andersson@polarcool.se
About PolarCool AB (publ.)
PolarCool AB (publ.) is a Swedish medical technology company focused on developing and marketing products in the sports medicine field. Its primary product, PolarCap®, is designed to reduce the impact of concussion through targeted brain cooling. PolarCool works with professional teams across Europe in rugby, football, and ice hockey and it shares are listed on Spotlight Stock Market.
